There is a noticeable urgency in the air, as evidenced by the U.S. Food and Drug Administration’s (FDA) approval of eight new drugs in December 2012. Legislation passed in 2012 has spurred FDA to . . . → Read More: The Life Sciences Report Watchlist 2013 Similar posts: Gold in 2013: Fund Managers Reveal Reasons for Optimism Five fund managers participated in the survey: Frank Holmes of... Pent-Up Potential for Precious Metals in 2013: Jason Hamlin TGR: Jason, you recently told your Gold Stock Bull readers... 2013 Should Be the Turnaround Year for Uranium: David Talbot The Energy Report: It’s been just over three months since...